Filing Details
- Accession Number:
- 0001562180-18-001804
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-03 18:49:08
- Reporting Period:
- 2018-04-01
- Accepted Time:
- 2018-04-03 18:49:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1620368 | Victor Sandor | C/O Array Biopharma Inc. 3200 Walnut Street Boulder CO 80301 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-04-01 | 7,812 | $0.00 | 225,711 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-04-01 | 6,936 | $16.32 | 218,775 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-04-03 | 8,689 | $15.35 | 210,086 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2018-04-01 | 7,812 | $0.00 | 7,812 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,626 | 2020-04-01 | No | 4 | M | Direct |
Footnotes
- Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by the Issuer on April 1, 2016 as a result of the vesting of one fourth of such RSUs.
- Includes (i) 7,813 unvested Restricted Stock Units ("RSUs") awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs, and (ii) 7,813 shares of common stock issued upon the vesting of these RSU's on April 1, 2018.
- Represents shares withheld to satisfy tax withholding obligations of the reporting person in connection with the vesting of RSUs held by the reporting person.
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request.
- The remaining RSUs vest and will be settled in stock in two equal annual installments on April 1, 2019 and 2020.
Billionaire Hedge Funds
